Access to anti-retroviral drugs, female in Azerbaijan
Azerbaijan: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Azerbaijan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Azerbaijan stood at 98.0%. That is the highest value across all 24 years on record.
That represents a change of up 10.1% on the previous year and up 292.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Azerbaijan peaked at 98.0% in 2024 and was at its lowest, 0.0%, in 2000.
Azerbaijan ranks 1st of 141 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Azerbaijan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 2.0% | — |
| 2008 | 3.0% | +50.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 6.0% | +50.0% |
| 2011 | 9.0% | +50.0% |
| 2012 | 12.0% | +33.3% |
| 2013 | 16.0% | +33.3% |
| 2014 | 25.0% | +56.2% |
| 2015 | 33.0% | +32.0% |
| 2016 | 41.0% | +24.2% |
| 2017 | 50.0% | +22.0% |
| 2018 | 59.0% | +18.0% |
| 2019 | 69.0% | +16.9% |
| 2020 | 73.0% | +5.8% |
| 2021 | 78.0% | +6.8% |
| 2022 | 80.0% | +2.6% |
| 2023 | 89.0% | +11.2% |
| 2024 | 98.0% | +10.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.0% | 0.0% | 4.0% | 9 |
| 2010s | 32.0% | 6.0% | 69.0% | 10 |
| 2020s | 83.6% | 73.0% | 98.0% | 5 |
Countries ranked near Azerbaijan
More gender data for Azerbaijan
- Child population (UN estimates and projections) 1,956 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -2.3 % change on previous year (2030)
- Population 8,710 (2030)
- Working-age population (UN estimates and projections) 8,710 (2030)
- Population (UN estimates and projections), annual growth rate 1.12 % change on previous year (2030)
- Age population, age 00, female, interpolated 56,657 (2025)
- Age population, age 00, male, interpolated 62,813 (2025)
- Age population, age 01, female, interpolated 57,383 (2025)
- Age population, age 01, male, interpolated 63,829 (2025)
- Age population, age 02, female, interpolated 58,825 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Azerbaijan?
- Access to anti-retroviral drugs, female in Azerbaijan was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Azerbaijan?
- The highest recorded value was 98.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Azerbaijan?
- The lowest recorded value was 0.0% in 2000.
- How does Azerbaijan rank for access to anti-retroviral drugs, female?
- Azerbaijan ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Azerbaijan?
- Over the last ten years it is up 292.0%. The long-run trend across the full record is volatile.
- Where does this Azerbaijan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.